Some clinical trials have shown the usefulness of stem cell therapy for diabetic foot ulcers. However, the donor supply is limited, and the process is time consuming and expensive. This… Click to show full abstract
Some clinical trials have shown the usefulness of stem cell therapy for diabetic foot ulcers. However, the donor supply is limited, and the process is time consuming and expensive. This study assessed the therapeutic effects of neonatal porcine bone marrow–derived mesenchymal stem cell (npBM‐MSC) xenotransplantation using diabetic wound model mice.
               
Click one of the above tabs to view related content.